Deepflare is a Warsaw-based biotech company that uses artificial intelligence to make the development of new vaccines and therapies faster and cheaper. Founded in 2020, it was inspired by the unprecedented speed of vaccine development during the COVID-19 pandemic and the rapid adoption of mRNA technology. The company builds machine learning models that help scientists design vaccine constructs, optimise protein function and engineer new proteins. It also offers manufacturing analytics for cell-based therapies, helping producers improve quality and consistency. Deepflare works mainly with biopharmaceutical companies and research teams that want to shorten the path from idea to drug candidate. Its backers include Sunfish Partners, Lemonade Stand, the Polish Development Fund (PFR) and the National Centre for Research and Development (NCBR).

‍